Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

ETX.L News

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)
10 Jun 2019

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20...

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs
5 Mar 2019

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the ...

UK Earnings, Trading Statements Calendar - Next 7 Days
26 Feb 2019

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

E-Therapeutics launches research collaboration with Novo Nordisk
10 Dec 2018

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeuti...

E-Therapeutics and C4X upbeat on Parkinson's collaboration
6 Dec 2018

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursd...

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment
6 Dec 2018

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additio...

e-Therapeutics narrows interim losses as it eyes commercial viability
4 Oct 2018

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs
4 Oct 2018

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its c...